cover
Contact Name
Yulia Nadar Indrasari
Contact Email
admin@indonesianjournalofclinicalpathology.org
Phone
+6285733220600
Journal Mail Official
majalah.jicp@yahoo.com
Editorial Address
Laboratorium Patologi Klinik RSUD Dr. Soetomo Jl. Mayjend. Prof. Dr. Moestopo 6-8 Surabaya
Location
Kota adm. jakarta selatan,
Dki jakarta
INDONESIA
Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML)
ISSN : 08544263     EISSN : 24774685     DOI : https://dx.doi.org/10.24293
Core Subject : Health, Science,
Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML) is a journal published by “Association of Clinical Pathologist” professional association. This journal displays articles in the Clinical Pathology and Medical Laboratory scope. Clinical Pathology has a couple of subdivisions, namely: Clinical Chemistry, Hematology, Immunology and Serology, Microbiology and Infectious Disease, Hepatology, Cardiovascular, Endocrinology, Blood Transfusion, Nephrology, and Molecular Biology. Scientific articles of these topics, mainly emphasize on the laboratory examinations, pathophysiology, and pathogenesis in a disease.
Articles 1,373 Documents
ADIPOSE TISSUE INSULIN RESISTANCE ANALYSIS IN SUBJECTS WITH OBESITY AND NON-OBESITY Lita Paramitha Apriani; Nurahmi; Liong Boy Kurniawan
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.2725

Abstract

Obesity is an increasing global health problem that is closely related to various metabolic complications, including insulin resistance. Adipose Tissue Insulin Resistance (Adipo-IR) is an important indicator that can reflect metabolic dysfunction that occurs in obesity. This study analyzed and compared Adipo-IR values ​​in obese and non-obese subjects, using a cross-sectional design and involving 82 subjects. The study subjects were divided into two groups, namely obese and non-obese groups, based on body mass index (BMI) classified according to Asia-Pacific criteria. Adipo-IR measurements were performed by calculating fasting insulin levels and free fatty acids (FFA). Statistical analysis showed that the obese group had an average fasting insulin level of 20.19±15.07 mIU/L, while the non-obese group was 9.39±6.12 mIU/L, indicating a significant difference in fasting insulin levels in both groups of subjects (p <0.001). The FFA levels of the obese group had an average of 0.25±0.27 mmol/L and the average FFA levels of the non-obese group were 0.21±0.24 mmol/L, indicating that there was no significant difference in the FFA levels of the two groups of subjects (p = 0.212). The Adipo-IR value of the obese group had an average of 4.89±6.27 while the average value of the non-obese group was 2.39±3.67, indicating a significant difference in Adipo-IR values ​​in both groups of subjects (p = 0.003). There was a significant positive correlation between Adipo-IR and BMI values ​​(r = 0.330, p = 0.002), indicating that increased BMI was associated with increased Adipo-IR values. Higher Adipo-IR values ​​in the obese group indicate an increased likelihood that the subject has adipose tissue insulin resistance.
GENETIC PREDICTORS AND BIOMARKERS IN TUBERCULOSIS INFECTION: A SYSTEMATIC REVIEW OF VARIANTS ACROSS POPULATIONS Riski Irawan Putra Priyono; Kusworini Handono; Dewi Santosaningsih; Susanthy Djajalaksana
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2744

Abstract

Toll-like receptor (TLR) polymorphisms may influence susceptibility to extrapulmonary tuberculosis (EPTB). This systematic review examines the association between TLR polymorphisms and EPTB risk and summarizes pulmonary TB (PTB) data from the same studies for phenotype comparison across populations. A comprehensive search of PubMed, Web of Science, and Scopus was conducted using relevant keywords. The study followed PRISMA guidelines, and Mendeley was used for reference management. Studies assessing the association between TLRs polymorphisms and EPTB susceptibility, progression, or treatment outcomes in human subjects were included, while non-human studies and unrelated research were excluded. The Joanna Briggs Institute (JBI) checklist was used to assess study validity. The extracted data included study details, population, control group, and outcomes. Of 620 records, 212 were screened, and 11 met the inclusion criteria. Evidence largely from Asians implicates TLR2 variants in disease risk: Arg753Gln was associated with pulmonary TB and TB peritonitis; the Del/Del genotype conferred strong EPTB risk; and 597CC/T597C showed phenotype‑ and population‑specific effects, including meningeal TB. A TIRAP (TLR adaptor) C558T variant was linked to higher TB susceptibility, with stronger effects in TB meningitis than pulmonary disease. Functional data in intraocular TB demonstrated augmented pro‑inflammatory CD4⁺ T‑cell responses after TLR2/TLR9 stimulation. The findings of this systematic review concluded that TLR2‑axis genetics appear to modulate TB risk, particularly for EPTB. These findings support phenotype‑specific risk stratification and highlight the need for multi‑ancestry studies with standardized endpoints and mechanistic validation.
CORRELATION BETWEEN STRESS HORMONE, INFLAMMATORY MARKER, AND ANTIBODY LEVELS IN COVID-19 PATIENTS Dwi Retnoningrum; Meita Hendrianingtyas; Rebriarina Hapsari; Setyo Gundi Pramudo; Edward Kurnia Setiawan Limijadi
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.2771

Abstract

Coronavirus disease-19 (COVID-19) is an infection that causes physical and psychological stress. Cortisol and prolactin are hormones that have been studied in association with infectious states. Viral infections trigger the production of acute-phase proteins and antibodies essential for viral elimination. This study aimed to prove the correlation between stress hormone levels and inflammatory markers and antibodies in COVID-19 patients. A cross-sectional approach was employed in this study, with a target population of patients with moderate-to-severe COVID-19. Cortisol, prolactin, and specific antibodies were quantified via ELISA, while CRP and procalcitonin levels were measured using immunoturbidimetric and immunofluorescence assays. Additionally, anti-SARS-CoV-2 antibodies were evaluated using the ECLIA principle. Statistical analysis was performed using the Spearman rank correlation test. Fifty-six subjects were included in this study. The study found correlations between cortisol and prolactin levels and CRP (p=0.007, r=0.357; p=0.132, r=0.204) and procalcitonin (p=0.006, r=0.365; p=0.315, r=0.137). The correlations between cortisol and prolactin levels and IgM were p=0.163, r=-0.189; and p=0.299, r=-0.141. The correlations between cortisol and prolactin levels and IgG were p=0.017, r=-0.317, and p=0.207, r=-0.171. There is a weak positive correlation between cortisol levels and CRP and procalcitonin levels. There is a weak negative correlation between cortisol levels and anti-SARS-CoV-2 IgG.
CLOT WAVE ANALYSIS IN LIVER CIRRHOSIS WITH NORMAL COAGULATION PROFILES : A PRELIMINARY STUDY YAN MARDIAN; SRI SURYO ADIYANTI
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.2821

Abstract

Patients with liver cirrhosis are at risk of developing coagulopathy, particularly bleeding complications. Conventional screening tests, such as Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), measure only clot formation time, offering limited insight into the comprehensive coagulation dynamics. Clot Wave Analysis (CWA), obtained from photo-optical coagulation analyzers, monitors real-time changes in transmitted light during fibrin formation, providing deeper insights into the coagulation process. Although earlier studies demonstrated CWA's utility in detecting coagulopathy in cirrhotic patients, its role in individuals presenting with normal PT and APTT values, or in early-stage cirrhosis, remains insufficiently explored. This preliminary cross-sectional study aimed to evaluate clot waveform characteristics using CWA in cirrhotic patients exhibiting normal coagulation profiles for the early identification of coagulation abnormalities. Waveforms from PT and APTT assays were qualitatively analyzed for patterns and quantitatively assessed using parameters including maximum velocity (Min 1, dT/dt), maximum acceleration (Min 2), maximum deceleration (Max 2, d²T/dt²), and maximum clot density (Delta, dH). This study enrolled 50 participants (25 cirrhotic patients and 25 healthy controls) with normal PT and APTT values. Qualitatively, cirrhotic patients exhibited flatter waveform slopes compared to controls. Quantitatively, significant reductions were observed in Min 1, Max 2, and Delta in CWA-PT and all parameters in CWA-APTT. CWA shows potential in detecting coagulopathy in cirrhotic patients with normal PT and APTT. Further studies are needed to establish standardized CWA reference values for clinical applications.
NRAS, RUNX1 POLYMORPHISM AND CHROMOSOME 5 DELETION [DEL(5q)] AS MYELODYSPLASTIC SYNDROME RELATED ACUTE MYELOID LEUKEMIA PREDICTOR IN SURABAYA Mulya Dinata; Siprianus Ugroseno Yudho Bintoro; Edi Widjajanto; Windhu Purnomo
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2828

Abstract

Myelodysplastic syndrome (MDS) is a well-organized hematopoiesis (Apoptosis) that becomes dysplastic and ineffective (Anti-Apoptosis). It is characterized by a slight increase in the number of immature blood cells (Blasts) in bone marrow, which can develop into acute myeloid leukemia (AML; MDS-related AML). In this study, Researchers sought to determine whether abnormalities in NRAS, RUNX1, and chromosome 5 deletion (del[5q]) can be used as predictors of MDS-related AML. This study employed an analytical cross-sectional design involving a total of 36 samples, consisting of 31 confirmed AML cases and 5 clinically diagnosed MDS cases. The occurrence of NRAS, RUNX1 mutations, and deletion of chromosome 5 deletion (del[5q]) was examined using polymerase chain reaction (PCR) and chromogenic in situ hybridization (CISH). Our analysis demonstrates that NRAS and RUNX1 mutations, alongside chromosome 5q deletion (del[5q]), are significantly associated with the progression of MDS-related AML.  Statistical evaluation via ROC curve showed an AUC of 0.765 (95% CI, p=0.036), demonstrating the model’s significant performance in predicting disease progression. Above or below the cut-off value (0.7825584010 ) indicates strong or weak predictions of MDS-related AML based on the ROC curve. Mutation of RUNX1 coefficient B-1.694 and exponent B 0.184 decreased the progression to MDS-related AML, while NRAS mutation coefficient 2.446 and exponent B 11.53 increased the progression of MDS-related AML. Normal cytogenetics of Chromosome 5, RUNX1 mutation inhibits progression, while NRAS mutation increases progression of MDS-related AML. NRAS and RUNX1 mutations, as well as Chromosome 5 deletion (del[5q]) can be strong predictors of progression to MDS-related AML in Surabaya.
Diagnostic Value of NE-WY and MO-WY for Rapid Identification Acute Leukemia Fisky Gilbert Asa Maramis; Anak Agung Wiradewi Lestari; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2830

Abstract

Rapid identification of acute leukemia is essential for its management. In resource-limited settings, simple, fast, and non-invasive initial screening methods are crucial for early detection. Cell population data (CPD) obtained from an automated hematology analyzer provides a new approach to identify acute leukemia quickly. Determine the ability of the width of dispersion of neutrophil fluorescence (NE-WY) and the width of dispersion of monocyte fluorescence (MO-WY), in rapidly identifying acute leukemia. The research was performed at Ngoerah Hospital Bali, focusing on patients recently diagnosed with acute leukemia. NE-WY and MO-WY values were measured using the Sysmex XN-3000 device. The study included healthy controls who had a medical check-up, and reactive controls, specifically patients with infections or inflammatory conditions. Patients who relapsed or previously received chemotherapy were excluded. A total of 228 subjects were involved in this study: 78 acute leukemia patients, 80 healthy controls, and 70 reactive controls. Distinguishing leukemia from healthy controls, the NE-WY cut-off value was 689, with sensitivity; 92.3%, specificity; 100% (p <0.001). While distinguishing from reactive controls, the cut-off value of NE-WY 857.5 was obtained, with sensitivity; 70.5%, specificity; 82.9% (p <0.001). In distinguishing leukemia from healthy controls, the cut-off value MO-WY 804 was obtained, with sensitivity; 52.6%, specificity; 96.3% (p <0.001). While distinguishing from reactive controls, the cut-off value of MO-WY 901 was obtained, with sensitivity; 46.1%, specificity; 85.7% (p = 0.299). NE-WY values indicated superior sensitivity and specificity compared to MO-WY in the early detection of acute leukemia.
CORRELATION AND DISCREPANCY BETWEEN SEROLOGY AND MOLECULAR TEST IN TRANSFUSION-TRANSMITTED INFECTION IN SURABAYA BLOOD DONOR UNIT Ilham Wildan Ahmad; Diah Puspita Rini
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2877

Abstract

Transfusion-transmitted-infection (TTI) screening is an important process in blood banks to minimize the risk of transmission during transfusion. To date, the primary pathogens screened for TTIs include hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Treponema pallidum (syphilis). Currently, serology is still most widely used in Indonesia. Nucleic acid test (NAT) has been used in developed countries due to earlier detection and greater sensitivity compared to serology. Several reports found discrepancies between NAT and serology. Indonesia widely uses serology and is beginning to use NAT for TTI screening. To analyze the correlation and discrepancy between chemiluminescence Immunoassay (CLIA) and NAT in TTI screening. This retrospective study included all donor samples evaluated for serology and NAT as part of TTI screening between May and December 2024. Serology used Abbott Alinity, while NAT used Procleix with screening reagents. Positive results were verified by NAT with specific reagents. This study included 6,335 samples: 6,320 (99.76%) were negative for both methods, 2 samples (0.03%) were positive for both methods, and 13 samples (0.21%) showed a discrepancy. The correlation study showed a significant result (p <0.001). Positive serology and negative NAT were found in 8 samples (0.13%) with low reactive indices. Final result after verification with confirmation NAT showed that all samples were negative. Negative serology and positive NAT were found in 5 samples (0.08%), which confirmed 3 positives for hepatitis B, 1 for HIV, and 1 negative result. This study showed a concordance rate of 99.79% between serology and NAT. Utilizing serology in parallel with NAT in TTI screening will be beneficial.
Discriminative Performance of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Differentiating Acute Lymphoblastic Leukemia From Myeloid Leukemia in Children I Dewa Ayu Agung Sridharaswari; Mia Ratwita Andarsini; Maria Christina Shanty Larasati; I Dewa Gede Ugrasena; I Gusti Agung Ayu Putri Sri Rejeki
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2964

Abstract

Early differentiation between Acute Lymphoblastic Leukemia (ALL) and myeloid leukemia is clinically important because therapeutic strategies differ substantially. Definitive diagnosis requires bone marrow examination supported by immunophenotyping. However, complete blood count (CBC) parameters are usually available earlier in the initial evaluation. Hematologic ratios derived from CBC, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), may provide supportive information during early clinical assessment. To evaluate the discriminative performance of NLR and PLR in differentiating pediatric ALL from myeloid leukemia. A retrospective cross-sectional study was conducted using medical records of children aged 0–18 years with leukemia, which had been confirmed by bone marrow examination at a tertiary referral hospital. Neutrophil-to-lymphocyte ratio (NLR) and PLR were analyzed as continuous variables using Receiver Operating Characteristic (ROC) curve analysis. Optimal cut-off values were determined using Youden’s Index. Logistic regression analysis was performed to evaluate the association between these ratios and the ALL status. A total of 506 pediatric leukemia cases were included (428 ALL and 78 myeloid leukemia). The Median of NLR was significantly lower in ALL compared to myeloid leukemia (0.11 vs 1.09; p <0.001). The NLR demonstrated good discriminative ability with an AUC of 0.869 (95% CI 0.823–0.914). The optimal cut-off value of 0.415 yielded 82.7% sensitivity and 76.9% specificity. In multivariate analysis, lower NLR remained independently associated with ALL (OR 0.811; 95% CI 0.693–0.951; p =0.010). platelet-to-lymphocyte ratio (PLR) showed modest discrimination (AUC 0.611) and did not retain independent significance after adjustment. Neutrophil-to-lymphocyte ratio (NLR) demonstrates good discriminative performance for differentiating ALL from myeloid leukemia and may serve as a supportive triage parameter during initial evaluation. However, it should not replace standard diagnostic procedures such as bone marrow examination and immunophenotyping.
Erratum to “Antifungal Ability as an Antimicrobial of Eucalyptus Oil (Melaleuca leucadendra) in Inhibiting the Growth of Candida albicans”[Published Issue of Indonesian Journal of Clinical Pathology and Medical Laboratory July 2025, 31(3): p. 280, 282] Wiwin Retnowati; Ichsan Abdillah; Ardiansah Bayu Nugroho
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.3031

Abstract

This erratum is to explain a typographical error in Title, abstract and content that occurred in the published issue of Indonesian Journal of Clinical Pathology and Medical Laboratory Volume 31, Number 3 in July 2025, pages 280 and 282. The error was in writing the Title with no space, a typo of word at page 280 and 282. We have included the corrections below.
Correlation of NS1 Antigen and Dengue Virus Serotype with Infection Status in Dengue Patients Anindya Widyasari; Aryati; Hantoro Gunawan; Puspa Wardhani; Lulut Kusumawati; Nasronudin; Betty Agustina Tambunan; Atika
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.3078

Abstract

Non-structural protein 1 (NS1) antigen is an important biomarker for the early diagnosis of dengue virus infection. However, NS1 detection may be influenced by dengue virus serotype and the host immune response during primary and secondary infections, with inconsistent findings reported across previous studies. To investigate the association between NS1 antigen positivity, dengue virus serotypes, and infection status in patients with RT-PCR-confirmed dengue infection. An analytical cross-sectional study was conducted among 65 hospitalized patients with RT-PCR-confirmed dengue infection. Blood samples were collected within the first five days after fever onset (median, 3 days; range, 1–5 days). Dengue virus serotypes were identified using the STANDARD M10 Arbovirus Panel, while infection status was determined using the STANDARD F Dengue IgM/IgG fluorescence immunoassay. Associations between NS1 antigen positivity, dengue virus serotypes, and infection status were analyzed using Fisher's exact test. Among 65 RT-PCR-confirmed cases, 55 (84.6%) were NS1-positive, and 10 (15.4%) were NS1-negative. Serotype distribution was DENV-1 (36.9%), DENV-2 (21.5%), DENV-3 (29.2%), DENV-4 (9.2%), and mixed DENV-2/DENV-3 infection (3.1%). No significant associations were found between NS1 antigen positivity and dengue virus serotypes (p = 0.969) or infection status (p = 0.456). Although NS1 positivity was higher in primary than secondary infections (86.4% vs. 66.7%), the difference was not statistically significant. NS1 antigen positivity was not significantly associated with dengue virus serotypes or infection status. The high NS1 positivity observed in this study may reflect early specimen collection during the acute phase of illness, regardless of infection status or viral serotype.

Filter by Year

2005 2026


Filter By Issues
All Issue Vol. 32 No. 3 (2026) Vol. 32 No. 2 (2026) Vol. 32 No. 1 (2025) Vol. 31 No. 3 (2025) Vol. 31 No. 2 (2025) Vol. 31 No. 1 (2024) Vol. 30 No. 3 (2024) Vol. 30 No. 2 (2024) Vol. 30 No. 1 (2023) Vol. 29 No. 3 (2023) Vol. 29 No. 2 (2023) Vol. 29 No. 1 (2022) Vol 29, No 1 (2022) Vol 28, No 3 (2022) Vol. 28 No. 3 (2022) Vol. 28 No. 2 (2022) Vol 28, No 2 (2022) Vol. 28 No. 1 (2021) Vol 28, No 1 (2021) Vol 27, No 3 (2021) Vol. 27 No. 3 (2021) Vol. 27 No. 2 (2021) Vol 27, No 2 (2021) Vol. 27 No. 1 (2020) Vol 27, No 1 (2020) Vol 26, No 3 (2020) Vol. 26 No. 3 (2020) Vol. 26 No. 2 (2020) Vol 26, No 2 (2020) Vol 26, No 1 (2019) Vol. 26 No. 1 (2019) Vol. 25 No. 3 (2019) Vol 25, No 3 (2019) Vol. 25 No. 2 (2019) Vol 25, No 2 (2019) Vol 25, No 1 (2018) Vol. 25 No. 1 (2018) Vol 24, No 3 (2018) Vol. 24 No. 3 (2018) Vol. 24 No. 2 (2018) Vol 24, No 2 (2018) Vol. 24 No. 1 (2017) Vol 24, No 1 (2017) Vol 23, No 3 (2017) Vol. 23 No. 3 (2017) Vol 23, No 2 (2017) Vol. 23 No. 2 (2017) Vol 23, No 1 (2016) Vol 22, No 3 (2016) Vol 22, No 2 (2016) Vol 22, No 1 (2015) Vol 21, No 3 (2015) Vol 21, No 2 (2015) Vol 21, No 1 (2014) Vol 20, No 3 (2014) Vol 20, No 2 (2014) Vol 20, No 1 (2013) Vol 19, No 3 (2013) Vol 19, No 2 (2013) Vol 19, No 1 (2012) Vol. 19 No. 1 (2012) Vol 18, No 3 (2012) Vol. 18 No. 3 (2012) Vol 18, No 2 (2012) Vol 18, No 1 (2011) Vol. 18 No. 1 (2011) Vol 17, No 3 (2011) Vol 17, No 2 (2011) Vol 17, No 1 (2010) Vol 16, No 3 (2010) Vol 16, No 2 (2010) Vol 16, No 1 (2009) Vol 15, No 3 (2009) Vol 15, No 2 (2009) Vol 15, No 1 (2008) Vol 14, No 3 (2008) Vol 14, No 2 (2008) Vol 14, No 1 (2007) Vol 13, No 3 (2007) Vol 13, No 2 (2007) Vol 13, No 1 (2006) Vol 12, No 3 (2006) Vol 12, No 2 (2005) Vol 12, No 1 (2005) More Issue